Ronald G. Schwartz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ronald G. Schwartz has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
Maria L. Mackin
Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, USA
4 shared publicationsErin M. Armenia
Cardiology Division, Department of Medicine (P.H., A.J., J.F., N.A., E.M.A., M.L.M., S.L., S.A., P.B., L.C., R.G.S.), University of Rochester, NY
3 shared publicationsAnas Jawaid
Cardiology Division, Department of Medicine (P.H., A.J., J.F., N.A., E.M.A., M.L.M., S.L., S.A., P.B., L.C., R.G.S.), University of Rochester, NY
2 shared publicationsErica O. Miller
Cardiology Division, Department of Medicine, University of Rochester Medical Center Rochester, Rochester, New York
2 shared publicationsJesse A. Doran
Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, USA
2 shared publicationsMarabel D. Schneider
Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, USA
2 shared publications
Latest Publications
- 1 August 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 19  (8)
Quantitative CZT SPECT Myocardial Blood Flow for Physiological Assessment and Risk Stratification of Cardiac Allograft Vasculopathy
BACKGROUND: Cardiac allograft vasculopathy (CAV) remains a major cause of morbidity and mortality after orthotopic heart transplantation. Although positron emission tomography myocardial perfusion imaging with quantitative myocardial blood flow (MBF) effectively detects CAV, access remains limited. Cadmium-zinc-telluride (CZT) single-photon emission computed tomography (SPECT) enables quantitative MBF assessment and may provide a more accessible alternative. However, the diagnostic and prognostic value of quantitative CZT SPECT-derived MBF for CAV is unknown. METHODS: We retrospectively studied 110 consecutive orthotopic heart transplantation recipients who underwent coronary angiography and CZT SPECT quantitative MBF imaging within 12 months. Stress MBF, rest MBF, MBF reserve, coronary flow capacity, and total perfusion deficit were compared across International Society for Heart and Lung Transplantation CAV categories. The diagnostic performance of the established (Bravo) and modified (Hart) flow-based algorithms was evaluated by receiver operating characteristic analysis. Associations with CAV-related events were assessed. RESULTS: Over 2.3±1.0 years, stress MBF declined progressively with increasing CAV severity ( P =0.007) and was lower in patients with CAV 2 to 3 than in those with CAV 0 to 1 (1.25±0.52 versus 2.03±0.81 mL/min per g; P =0.003). The Bravo and Hart algorithms showed similar discrimination of advanced CAV by paired DeLong comparison (area under the curve, 0.773 versus 0.717; Δ area under the curve, 0.056; P =0.606). Severely reduced coronary flow capacity was associated with higher event rates (28.6% versus 5.2%; P =0.015). The Hart framework demonstrated exploratory prognostic separation (35.3% versus 3.2%; P =0.001). CONCLUSIONS: Quantitative CZT SPECT-derived MBF and coronary flow capacity provide physiological assessment and risk stratification of CAV, with preliminary associations with CAV-related events. These findings support the prospective multicenter evaluation of CZT SPECT MBF as a widely available, noninvasive orthotopic heart transplantation surveillance strategy.
- 1 August 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 19  (8)
Quantitative CZT SPECT Myocardial Blood Flow for Physiological Assessment and Risk Stratification of Cardiac Allograft Vasculopathy
BACKGROUND: Cardiac allograft vasculopathy (CAV) remains a major cause of morbidity and mortality after orthotopic heart transplantation. Although positron emission tomography myocardial perfusion imaging with quantitative myocardial blood flow (MBF) effectively detects CAV, access remains limited. Cadmium-zinc-telluride (CZT) single-photon emission computed tomography (SPECT) enables quantitative MBF assessment and may provide a more accessible alternative. However, the diagnostic and prognostic value of quantitative CZT SPECT-derived MBF for CAV is unknown. METHODS: We retrospectively studied 110 consecutive orthotopic heart transplantation recipients who underwent coronary angiography and CZT SPECT quantitative MBF imaging within 12 months. Stress MBF, rest MBF, MBF reserve, coronary flow capacity, and total perfusion deficit were compared across International Society for Heart and Lung Transplantation CAV categories. The diagnostic performance of the established (Bravo) and modified (Hart) flow-based algorithms was evaluated by receiver operating characteristic analysis. Associations with CAV-related events were assessed. RESULTS: Over 2.3±1.0 years, stress MBF declined progressively with increasing CAV severity ( P =0.007) and was lower in patients with CAV 2 to 3 than in those with CAV 0 to 1 (1.25±0.52 versus 2.03±0.81 mL/min per g; P =0.003). The Bravo and Hart algorithms showed similar discrimination of advanced CAV by paired DeLong comparison (area under the curve, 0.773 versus 0.717; Δ area under the curve, 0.056; P =0.606). Severely reduced coronary flow capacity was associated with higher event rates (28.6% versus 5.2%; P =0.015). The Hart framework demonstrated exploratory prognostic separation (35.3% versus 3.2%; P =0.001). CONCLUSIONS: Quantitative CZT SPECT-derived MBF and coronary flow capacity provide physiological assessment and risk stratification of CAV, with preliminary associations with CAV-related events. These findings support the prospective multicenter evaluation of CZT SPECT MBF as a widely available, noninvasive orthotopic heart transplantation surveillance strategy.
- 21 March 2026
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 57, 102657
Patient-centered care: Assessing coronary artery calcification and exercise ability in patients referred for nuclear cardiology stress testing
- 21 March 2026
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 57, 102657
Patient-centered care: Assessing coronary artery calcification and exercise ability in patients referred for nuclear cardiology stress testing
- Open Access
- 1 March 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211  (3) , 436-451
Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement
Background: Lung cancer screening with low-dose computed tomography (LDCT) may uncover incidental findings (IFs) unrelated to lung cancer. There may be potential benefits from identifying clinically significant IFs that warrant intervention and potential harms related to identifying IFs that are not clinically significant but may result in additional evaluation, clinician effort, patient anxiety, complications, and excess cost. Objectives: To identify knowledge and research gaps and develop and prioritize research questions to address the approach to and management of IFs. Methods: We convened a multidisciplinary panel to review the available literature on IFs detected in lung cancer screening LDCT examinations, focusing on variability and standardizing reporting, management of IFs, and evaluation of the benefits and harms of IFs, particularly cardiovascular-related IFs. We used a three-round modified Delphi process to prioritize research questions. Results: This statement identifies knowledge gaps in 1) reporting of IFs, 2) management of IFs, and 3) identifying and reporting coronary artery calcification found on lung cancer screening LDCT. Finally, we present the panel’s initial 36 research questions and the final 20 prioritized questions. Conclusions: This statement provides a prioritized research agenda to further efforts focused on evaluating, managing, and increasing awareness of IFs in lung cancer screening.
- 1 March 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211  (3) , 436-451
Open AccessLung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement
Background: Lung cancer screening with low-dose computed tomography (LDCT) may uncover incidental findings (IFs) unrelated to lung cancer. There may be potential benefits from identifying clinically significant IFs that warrant intervention and potential harms related to identifying IFs that are not clinically significant but may result in additional evaluation, clinician effort, patient anxiety, complications, and excess cost. Objectives: To identify knowledge and research gaps and develop and prioritize research questions to address the approach to and management of IFs. Methods: We convened a multidisciplinary panel to review the available literature on IFs detected in lung cancer screening LDCT examinations, focusing on variability and standardizing reporting, management of IFs, and evaluation of the benefits and harms of IFs, particularly cardiovascular-related IFs. We used a three-round modified Delphi process to prioritize research questions. Results: This statement identifies knowledge gaps in 1) reporting of IFs, 2) management of IFs, and 3) identifying and reporting coronary artery calcification found on lung cancer screening LDCT. Finally, we present the panel’s initial 36 research questions and the final 20 prioritized questions. Conclusions: This statement provides a prioritized research agenda to further efforts focused on evaluating, managing, and increasing awareness of IFs in lung cancer screening.
- 28 March 2024
- Published by Elsevier in Journal of Medical Imaging and Radiation Sciences
- Vol. 55  (2) , S64-S80
Advances in Clinical Care with Contemporary Cardiac SPECT
- 28 March 2024
- Published by Elsevier in Journal of Medical Imaging and Radiation Sciences
- Vol. 55  (2) , S64-S80
Advances in Clinical Care with Contemporary Cardiac SPECT
- Open Access
- 29 June 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30  (5) , 2254-1
Retraction Note: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI
- 29 June 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30  (5) , 2254-1
Open AccessRetraction Note: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI
- 31 May 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30  (4) , 1301-1307
What is this image? 2023 image 1 results: Precision high-resolution CZT SPECT imaging to evaluate cardiac aTTR amyloidosis
- 31 May 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30  (4) , 1301-1307
What is this image? 2023 image 1 results: Precision high-resolution CZT SPECT imaging to evaluate cardiac aTTR amyloidosis
- 1 April 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30  (2) , 570-573
Optimizing patient centered care in the cardiac intensive care unit: Harness the safety, effectiveness, and incremental value of radionuclide perfusion, function, and molecular imaging
- 1 April 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30  (2) , 570-573
Optimizing patient centered care in the cardiac intensive care unit: Harness the safety, effectiveness, and incremental value of radionuclide perfusion, function, and molecular imaging
- Open Access
- 22 January 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30  (6) , 2803-2806
Detection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: The expanding value proposition for clinical cardiology
- 22 January 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30  (6) , 2803-2806
Open AccessDetection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: The expanding value proposition for clinical cardiology
- 1 January 2021
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 29  (6) , 3461-3465
LVEF reserve: State of the heart is a matter of time, jeopardy and ischemic memory
- 1 January 2021
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 29  (6) , 3461-3465
LVEF reserve: State of the heart is a matter of time, jeopardy and ischemic memory
- 1 August 2020
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 27  (4) , 1098-1099
What Is This Image? 2020: Image 1 Result
- 1 August 2020
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 27  (4) , 1098-1099
What Is This Image? 2020: Image 1 Result